Brandy Vaughan was found dead by her 10 year old son on December 8, 2020. Rest in Peace….
She ran the website Learn the Risk dot org
* * *
In 2010, it was found that roughly 100,000 Americans die each year from prescription drugs alone. When it comes to opioids, the number of deaths is in the tens of thousands while a quarter of patients who were given a short-term prescription transitioned to long-term use.
Now, according to a recent Harvard University analysis, doctors who prescribe these pain-killers are being paid huge sums of money from their manufacturers.
The research, which was conducted by Harvard scientists and CNN, discovered that in 2014-2015 thousands of doctors were paid over $25,000 from opioid manufacturers and hundreds more were rewarded with six-figure sums. Also, the more opioids that were prescribed, the larger the reward.
H/t reader eric:
“And on and on…”
* * *
By Dr. Mercola
Direct-to-consumer (DTC) drug advertising, which began in 1997, has done a lot more than make Pharma arguably the most profitable industry in the world and a Wall Street success story. It has greatly increased the number of prescription drugs that Americans take. In 1992, five years before DTC advertising began, Americans took an average of seven prescription drugs a year. A mere 15 years later that number had nearly doubled to 12 per year.1,2
To sell drugs, aggressive drug advertising whips up fears over rare diseases like exocrine pancreatic insufficiency (introduced at the 2017 Super Bowl) and make a disease out of common, nearly universal conditions to frighten and motivate people into taking prescription drugs.
Another DTC advertising tactic is convincing people to take drugs simply because they might be “at risk” of a condition. Sadly, drug advertising is not the only way Pharma gets dangerous drugs into the nation’s medicine chests. Thanks to outrageous conflicts of interest at the U.S. Food and Drug Administration (FDA) — the new FDA Commissioner, Dr. Scott Gottlieb, is a drug company consultant — drugs that would once have not been approved fly through their approvals.
Personally, I would never ever take (deadly) drugs like Xarelto.
By Dr. Mercola
If you have noticed that prescription drugs are becoming more dangerous — and more expensive — you are right. As the drug industry’s influence over the U.S. Food and Drug Administration (FDA) increases, dangerous drugs are approved and marketed despite their clear risks to patients.
Recent examples include the aggressively promoted blood thinners Xarelto and Pradaxa which cause uncontrollable bleeding, the testosterone drug Androgel, for “Low T” linked to noncalcified plaque buildup in coronary arteries, and fluoroquinolone antibiotics. When warnings are added to these dangerous drugs or they are withdrawn, like 28 popular drugs have been, many wonder why media failed to report the safety risks while they were occurring.1
START – Theresa May to focus on Brexit transition agreement
02:11 – Mogherini’s EU military: a global security provider…
07:54 – RAF has a new Qatari wing: meet 12 squadron
09:28 – Behavioural change in the NHS: a force for good or not…?
UK Column analysis with Dr Graham Downing
26:53 – BBC uses RIPA terrorism laws to catch TV licence fee “dodgers”
30:53 – Child sexual abuse: Shatterboys UK revisited
37:50 – Scottish economy growth estimates below 1% until 2022…
39:31 – BBC fake news: Russia – a ‘new risk’ to undersea cables…
H/t reader squodgy:
We reallt do have a serious problem with the BigPharma bulldozer.”
* * *
by Jon Rappoport
December 13, 2017
The old question about a tree falling in the forest is relevant here. Does the tree make a sound if no one is there to hear it?
If a scandal erupts and the press doesn’t cover it, is it a scandal?
If this sounds strange, consider that, since the dawn of time, whatever has passed for mainstream news has substituted for the direct observation of events by humans. The press has functioned as the eyes and ears and even mouths of the public.
One out of every three American adults take statins, and if you think that sounds like good news for statin manufacturers, you’re missing the bigger picture. All of Big Pharma benefits when people take statins. In fact, statins can really be thought of as gateway drugs. After all, they have so many side effects that you will likely end up taking several other medications after you start statins just to deal with them.
What can happen to you if you take these dangerous drugs? They suppress your body’s immune system, rendering it less able to fight off infections. They also inhibit production of coenzyme Q10, which helps to regulate your immune and nervous system and maintain a healthy heart and blood pressure. There’s also a higher risk of neurological diseases when you take statins, with many patients reporting forgetfulness, confusion and memory loss. But don’t worry – whatever happens to you, Big Pharma has a solution for that, too!
The Drug Enforcement Agency (DEA) is now free to ban all access to a plant known as kratom (Mitragyna speciosa) that for centuries has served as a natural remedy for pain, and that’s helped countless opiate addicts overcome withdrawal symptoms. The federal government claims that kratom serves no legitimate medical purpose, but a closer look reveals that not only is the opposite true, but drug companies actually hold patents on kratom’s medicinal compounds. Public uproar after the DEA announced its plans has led to the agency saying in statements that it has no “timetable for officially listing kratom—it could be next week or longer—leaving users on the edge of their seats,” according to ARS Technica.
The DEA plans to classify kratom as a “Schedule I” drug – the highest classification reserved for hard drugs like heroin – and claims that kratom has a high potential for abuse and serves no legitimate purpose in health. However, several patents, including one dating back to 1964, show that kratom’s alkaloid compounds indeed exhibit pharmacodynamic activity.
Three compounds in particular – MGM-9, MGM-15, and MGM-16 – serve as proof that kratom holds therapeutic potential. Each of these synthetic opioid compounds was synthesized from various alkaloids present in the kratom plant; MGM-9 came from a compound known as mitragynine, while MGM-15 and MGM-16 came from 7-hydroxymitragynine. These two compounds are considered to be among the primary active constituents in kratom.